-
Most Recent
Search Results
240 results for CIE
National Iced Tea Day: Get Free Tea at Starbucks Corporation Today
Starbucks Corporation is offering a free iced tea to customers today for National Iced Tea Day after they purchase their first one.
CAE Stock Earnings: CAE Misses EPS, Misses Revenue for Q1 2025
CAE stock results show that CAE missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025.
CAE Stock Earnings: CAE Misses EPS, Misses Revenue for Q4 2024
CAE stock results show that CAE missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2024.
Rita’s Italian Ice: Get Your Free Italian Ice on March 20
Rita’s Italian Ice is celebrating the first day of spring with free flavored ice to those who show up at one of its locations. Here’s…
CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q3 2023
CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.
Ex-Dividend Reminders Include Iron Mountain Incorporated (IRM) and Knoll Inc (KNL)
Knoll, CAE, and Iron Mountain will all trade ex-dividend on June 13. Here are the payout dates for IRM, CAE and KNL stock
CME Stock Earnings: CME Gr Beats EPS, Beats Revenue for Q2 2024
CME stock results show that CME Gr beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q2 2024
CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
CUE Stock Earnings: Cue Biopharma Misses EPS, Beats Revenue for Q4 2023
CUE stock results show that Cue Biopharma missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
CME Stock Earnings: CME Gr Beats EPS, Beats Revenue for Q1 2024
CME stock results show that CME Gr beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q1 2024
CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Newmont Gold-plates its Dividend
The company ties its payout to gold prices
Target Unicorn Magic Ice Cream Makes Headlines
Target (TGT) announced that it is rolling out a “Unicorn Magic” ice cream, which was described as a “cherry flavored ice cream” with sour blue…
Is Facebook Finally Going to Die?
Facebook stock has come under intense pressure in recent weeks over how the company’s social media platforms impact the mental health of young folks. While…
The GDP Report Is Lying to You
Today’s GDP report came in higher than expected. Here’s why investors should take that with a grain of salt.
Bulls Skating on Thin Ice
A break below the Dow’s October lows would seal the deal for the bears.
The 2023 Bull Market Was a Lie
Investors have been arguing that we are in a new bull market in 2023. That is a lie… and ignoring the truth is dangerous.
What Lies Ahead For the Markets?
The news in the markets is really all about when and how much the Fed’s taper will begin, and here’s my view on the situation
The 2 Biggest Lies of Buybacks
S&P 500 companies have spent $211 billion in 2014 buying back stock. But here’s why buybacks aren’t always as good as they seem.
Cue the Biotech M&A Attack!
A rush of buyout activity in biotechs like Human Genome and Illumina could produce more frenzied M&A deals down the road.
This Market Upturn Is on Thin Ice
The Dow just missed a five-year high, but a narrow trading range is making this advance difficult to trust. Stay on the sidelines and keep…
What Happens If the Euro Dies?
The dissolution of the eurozone isn’t a likely scenario, but investors should at least be mindful of the worst. Here’s the potential fallout of a…
10 – 10 of 240 results
